Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$716K Buy
116,222
+63,504
+120% +$341K ﹤0.01% 2441
2026
Q1
$288K Buy
+52,718
New +$293K ﹤0.01% 2668
2025
Q3
Sell
-221,669
Closed -$505K 2576
2025
Q2
$505K Buy
221,669
+62,617
+39% +$170K ﹤0.01% 2484
2025
Q1
$441K Buy
159,052
+2,069
+1% +$5.71K ﹤0.01% 2517
2024
Q4
$482K Buy
156,983
+31,168
+25% +$109K ﹤0.01% 2558
2024
Q3
$533K Buy
125,815
+6,141
+5% +$27.1K ﹤0.01% 2624
2024
Q2
$482K Buy
119,674
+102,374
+592% +$455K ﹤0.01% 2638
2024
Q1
$86.2K Buy
+17,300
New +$83.6K ﹤0.01% 2497

Other funds holding SVRA

UBS AM's SVRA Position: Q2 2026 in Review

UBS AM increased its Savara (SVRA) stake by 120% in Q2 2026, buying an estimated $341K and bringing the position to 116,222 shares worth $716K. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

UBS AM first reported a position in SVRA in Q1 2024 and has held it in 8 quarters since. 181 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • UBS AM held 116,222 shares of Savara worth $716K as of Q2 2026.
  • UBS AM bought 63,504 Savara shares in Q2 2026, an estimated $341K.
  • Savara made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2441 holding.
  • UBS AM first reported a position in Savara in Q1 2024 and has held it in 8 quarters since.
  • 181 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.